Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study [PAPERS]

Conclusions
Methylene blue used as an adjunctive medication improved residual symptoms of depression and anxiety in patients with bipolar disorder.

Source: The British Journal of Psychiatry - January 3, 2017 Category: Psychiatry Authors: Alda, M., McKinnon, M., Blagdon, R., Garnham, J., MacLellan, S., O'Donovan, C., Hajek, T., Nair, C., Dursun, S., MacQueen, G. Tags: PAPERS Source Type: research